Biologics Spine Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval byTim AllenJuly 8, 2025
Extremities Top Stories Alafair Biosciences Announces First Patient Enrolled in Multi-Center Study Evaluating VersaWrap® Tendon Protector for Achilles Repair byBree MillerJune 25, 2025
Spine ReGelTec Announces First Patient Treated in U.S. IDE Clinical Trial for HYDRAFIL System to Treat Chronic Low Back Pain byJosh SandbergJune 18, 2025
Spine Memorial Neurosurgeons Deliver Spine-Tingling Outcome for Adult Scoliosis Patient byJosh SandbergFebruary 25, 2025
Spine SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation byJosh SandbergOctober 10, 2024
Spine Synergy Spine Solutions announces completion of patient enrollment in the Synergy Disc® 2-Level IDE clinical trial byJosh SandbergSeptember 25, 2024
Spine Spinal Simplicity and inFormed Consent Announce Strategic Partnership to Enhance Patient Education and Informed Consent Experience in Lumbar Spine and SI Joint Procedures byJosh SandbergMay 29, 2024
Recon Regulatory Top Stories Lipogems Announces Last Patient Enrolled in the U.S. FDA IDE Arise Study for the Treatment of Knee Osteoarthritis byTim AllenApril 10, 2024
Spine BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease byTim AllenApril 8, 2024